The Patents (Isle of Man) Order 2013

Article 2

SCHEDULE U.K. Modifications of the Patents Act 1977 in its application to the Isle of Man

1.  References to the Crown shall be construed as including the Crown in right of the Government of the Isle of Man. U.K.

Commencement Information

I1 Sch. para. 1 in force at 11.11.2013, see art. 1

2.—(1) References to an Act of Parliament (including the Patents Act 1977) or to a provision of such an Act shall be construed as references to that Act or provision as it has effect in the Isle of Man. U.K.

(2) References to an Act of Tynwald shall be construed as references to it as amended or replaced by or under any other such enactment.

Commencement Information

I2 Sch. para. 2 in force at 11.11.2013, see art. 1

3.  References to a government department shall be construed as including references to a Department of the Government of the Isle of Man, and in relation to such a Department as if references to the Treasury were references to the Treasury of the Isle of Man. U.K.

Commencement Information

I3 Sch. para. 3 in force at 11.11.2013, see art. 1

4.  For the purposes of any arbitration in pursuance of the Patents Act 1977, and of the application thereto of the Arbitration Act 1976 (an Act of Tynwald)(1), the Act of 1977 shall be treated as an Act of Tynwald. U.K.

Commencement Information

I4 Sch. para. 4 in force at 11.11.2013, see art. 1

5.  In section 1 (patentable inventions), for subsections (3) and (4) substitute— U.K.

“(3) A patent shall not be granted for an invention the commercial exploitation of which would be contrary to public policy or morality.

(4) For the purposes of subsection (3) above exploitation shall not be regarded as contrary to public policy or morality only because it is prohibited by any law in force in the United Kingdom or any part of it.”.

Commencement Information

I5 Sch. para. 5 in force at 11.11.2013, see art. 1

6.  In section 5 (priority date), after subsection (5) insert— U.K.

“(6) References in subsection (5) above to a convention country include references to a country, other than the United Kingdom, which is a member of the World Trade Organisation.”.

Commencement Information

I6 Sch. para. 6 in force at 11.11.2013, see art. 1

7.  In sections 22(9)(b) (information prejudicial to national security) and 23(3)(b) (restrictions on applications abroad), for “indictment, to imprisonment” substitute “information, to custody”. U.K.

Commencement Information

I7 Sch. para. 7 in force at 11.11.2013, see art. 1

8.—(1) In section 32(9) (register of patents) omit “Subject to subsection (12) below,”. U.K.

(2) In section 32(11) omit “, subject to subsection (12) below,”.

Commencement Information

I8 Sch. para. 8 in force at 11.11.2013, see art. 1

9.  In section 40(6) (compensation of employees), in the definition of “relevant collective agreement”, for “Act 1974” substitute “(Consolidation) Act 1992”. U.K.

Commencement Information

I9 Sch. para. 9 in force at 11.11.2013, see art. 1

10.  In section 41 (amount of compensation), at the end add the following subsection— U.K.

“(12) In the Isle of Man an order made under section 40 above by the comptroller for the payment of any sums may be enforced as if it were a judgment or order of the court for the payment of money.”.

Commencement Information

I10 Sch. para. 10 in force at 11.11.2013, see art. 1

11.  Omit sections 44 and 45. U.K.

Commencement Information

I11 Sch. para. 11 in force at 11.11.2013, see art. 1

12.  In section 46(3)(c) (licences of right), for “European Economic Community” substitute “European Union”. U.K.

Commencement Information

I12 Sch. para. 12 in force at 11.11.2013, see art. 1

13.  For section 48 substitute— U.K.

“Compulsory licences: general

48.— (1) At any time after the expiration of three years, or of such other period as may be prescribed, from the date of the grant of the patent, any person may apply to the comptroller on one or more of the relevant grounds—

(a) for a licence under the patent;

(b) for an entry to be made in the register to the effect that licences under the patent are to be available as of right; or

(c) where the applicant is a government department, for the grant to any person specified in the application of a licence under the patent.

(2) Subject to sections 48A and 48B below, if he is satisfied that any of the relevant grounds are established, the comptroller may—

(a) where the application is under subsection (1)(a) above, order the grant of a licence to the applicant on such terms as the comptroller thinks fit;

(b) where the application is under subsection (1)(b) above, make such an entry as is there mentioned;

(c) where the application is under subsection (1)(c) above, order the grant of a licence to the person specified in the application on such terms as the comptroller thinks fit.

(3) An application may be made under this section in respect of a patent even though the applicant is already the holder of a licence under the patent; and no person shall be estopped or barred from alleging any of the matters specified in the relevant grounds by reason of any admission made by him, whether in such a licence or otherwise, or by reason of his having accepted a licence.

(4) In this section “the relevant grounds” means—

(a) in the case of an application made in respect of a patent whose proprietor is a WTO proprietor, the grounds set out in section 48A(1) below;

(b) in any other case, the grounds set out in section 48B(1) below.

(5) A proprietor is a WTO proprietor for the purposes of this section and sections 48A, 48B, 50 and 52 below if—

(a) he is a national of, or is domiciled in, a country which is a member of the World Trade Organisation; or

(b) he has a real and effective industrial or commercial establishment in such a country.

(6) A rule prescribing any such other period under subsection (1) above shall not be made unless a draft of the rule has been laid before, and approved by a resolution of, each House of Parliament.

Compulsory licences: WTO proprietors

48A.— (1) In the case of an application made under section 48 above in respect of a patent whose proprietor is a WTO proprietor, the relevant grounds are—

(a) where the patented invention is a product, that a demand in the United Kingdom for that product is not being met on reasonable terms;

(b) that by reason of the refusal of the proprietor of the patent concerned to grant a licence or licences on reasonable terms—

(i) the exploitation in the United Kingdom of any other patented invention which involves an important technical advance of considerable economic significance in relation to the invention for which the patent concerned was granted is prevented or hindered, or

(ii) the establishment or development of commercial or industrial activities in the United Kingdom is unfairly prejudiced;

(c) that by reason of conditions imposed by the proprietor of the patent concerned on the grant of licences under the patent, or on the disposal or use of the patented product or on the use of the patented process, the manufacture, use or disposal of materials not protected by the patent, or the establishment or development of commercial or industrial activities in the United Kingdom, is unfairly prejudiced.

(2) No order or entry shall be made under section 48 above in respect of a patent whose proprietor is a WTO proprietor unless—

(a) the applicant has made efforts to obtain a licence from the proprietor on reasonable commercial terms and conditions; and

(b) his efforts have not been successful within a reasonable period.

(3) No order or entry shall be so made if the patented invention is in the field of semi-conductor technology.

(4) No order or entry shall be made under section 48 above in respect of a patent on the ground mentioned in subsection (1)(b)(i) above unless the comptroller is satisfied that the proprietor of the patent for the other invention is able and willing to grant the proprietor of the patent concerned and his licensees a licence under the patent for the other invention on reasonable terms.

(5) A licence granted in pursuance of an order or entry so made shall not be assigned except to a person to whom the patent for the other invention is also assigned.

(6) A licence granted in pursuance of an order or entry made under section 48 above in respect of a patent whose proprietor is a WTO proprietor—

(a) shall not be exclusive;

(b) shall not be assigned except to a person to whom there is also assigned the part of the enterprise that enjoys the use of the patented invention, or the part of the goodwill that belongs to that part;

(c) shall be predominantly for the supply of the market in the United Kingdom;

(d) shall include conditions entitling the proprietor of the patent concerned to remuneration adequate in the circumstances of the case, taking into account the economic value of the licence; and

(e) shall be limited in scope and in duration to the purpose for which the licence was granted.

Compulsory licences: other cases

48B.— (1) In the case of an application made under section 48 above in respect of a patent whose proprietor is not a WTO proprietor, the relevant grounds are—

(a) where the patented invention is capable of being commercially worked in the United Kingdom, that it is not being so worked or is not being so worked to the fullest extent that is reasonably practicable;

(b) where the patented invention is a product, that a demand for the product in the United Kingdom—

(i) is not being met on reasonable terms, or

(ii) is being met to a substantial extent by importation from a country which is not a member State;

(c) where the patented invention is capable of being commercially worked in the United Kingdom, that it is being prevented or hindered from being so worked—

(i) where the invention is a product, by the importation of the product from a country which is not a member State,

(ii) where the invention is a process, by the importation from such a country of a product obtained directly by means of the process or to which the process has been applied;

(d) that by reason of the refusal of the proprietor of the patent to grant a licence or licences on reasonable terms—

(i) a market for the export of any patented product made in the United Kingdom is not being supplied, or

(ii) the working or efficient working in the United Kingdom of any other patented invention which makes a substantial contribution to the art is prevented or hindered, or

(iii) the establishment or development of commercial or industrial activities in the United Kingdom is unfairly prejudiced;

(e) that by reason of conditions imposed by the proprietor of the patent on the grant of licences under the patent, or on the disposal or use of the patented product or on the use of the patented process, the manufacture, use or disposal of materials not protected by the patent, or the establishment or development of commercial or industrial activities in the United Kingdom is unfairly prejudiced.

(2) Where—

(a) an application is made on the ground that the patented invention is not being commercially worked in the United Kingdom or is not being so worked to the fullest extent that is reasonably practicable; and

(b) it appears to the comptroller that the time which has elapsed since the publication in the journal of a notice of the grant of the patent has for any reason been insufficient to enable the invention to be so worked,

he may by order adjourn the application for such period as will in his opinion give sufficient time for the invention to be so worked.

(3) No order or entry shall be made under section 48 above in respect of a patent on the ground mentioned in subsection (1)(a) above if—

(a) the patented invention is being commercially worked in a country which is a member State; and

(b) demand in the United Kingdom is being met by importation from that country.

(4) No entry shall be made in the register under section 48 above on the ground mentioned in subsection (1)(d)(i) above, and any licence granted under section 48 above on that ground shall contain such provisions as appear to the comptroller to be expedient for restricting the countries in which any product concerned may be disposed of or used by the licensee.

(5) No order or entry shall be made under section 48 above in respect of a patent on the ground mentioned in subsection (1)(d)(ii) above unless the comptroller is satisfied that the proprietor of the patent for the other invention is able and willing to grant to the proprietor of the patent concerned and his licensees a licence under the patent for the other invention on reasonable terms.”.

Commencement Information

I13 Sch. para. 13 in force at 11.11.2013, see art. 1

14.—(1) In section 50(1) (applications under section 48), after “in respect of a patent” insert “whose proprietor is not a WTO proprietor”. U.K.

(2) In section 50(2), for “such an application” substitute “any application under section 48 above”.

Commencement Information

I14 Sch. para. 14 in force at 11.11.2013, see art. 1

15.  In the side note to section 51 (powers exercisable in consequence of a report of the Competition Commission) and in sections 51(1) and 53(2) (compulsory licences), for “Monopolies and Mergers Commission” substitute “Competition Commission”. U.K.

Commencement Information

I15 Sch. para. 15 in force at 11.11.2013, see art. 1

16.  For section 52 substitute— U.K.

“Opposition, appeal and arbitration

52.— (1) The proprietor of the patent concerned or any other person wishing to oppose an application under sections 48 to 51 above may, in accordance with rules, give to the comptroller notice of opposition; and the comptroller shall consider any opposition in deciding whether to grant the application.

(2) Where an order or entry has been made under section 48 above in respect of a patent whose proprietor is a WTO proprietor—

(a) the proprietor or any other person may, in accordance with rules, apply to the comptroller to have the order revoked or the entry cancelled on the grounds that the circumstances which led to the making of the order or entry have ceased to exist and are unlikely to recur;

(b) any person wishing to oppose an application under paragraph (a) above may, in accordance with rules, give to the comptroller notice of opposition; and

(c) the comptroller shall consider any opposition in deciding whether to grant the application.

(3) If it appears to the comptroller on an application under subsection (2)(a) above that the circumstances which led to the making of the order or entry have ceased to exist and are unlikely to recur, he may—

(a) revoke the order or cancel the entry; and

(b) terminate any licence granted to a person in pursuance of the order or entry subject to such terms and conditions as he thinks necessary for the protection of the legitimate interests of that person.

(4) Where an appeal is brought—

(a) from an order made by the comptroller in pursuance of an application under sections 48 to 51 above;

(b) from a decision of his to make an entry in the register in pursuance of such an application;

(c) from a revocation or cancellation made by him under subsection (3) above; or

(d) from a refusal of his to make such an order, entry, revocation or cancellation,

the Attorney General, the appropriate Law Officer within the meaning of section 4A of the Crown Suits (Scotland) Act 1857(2), the Attorney General for Northern Ireland or the Attorney General for the Isle of Man or such other counsel as any of them may appoint, shall be entitled to appear and be heard.

(5) Where an application under section 48 to 51 above or subsection (2) above is opposed, and either—

(a) the parties consent, or

(b) the proceedings require a prolonged examination of documents or any scientific or local investigation which cannot in the opinion of the comptroller conveniently be made before him,

the comptroller may at any time order the whole proceedings, or any question or issue of fact arising in them, to be referred to an arbitrator or arbiter agreed on by the parties or, in default of agreement, appointed by the comptroller.

(6) Where the whole proceedings are so referred, unless the parties otherwise agree before the award of the arbitrator or arbiter is made, and appeal shall lie from the award to the court.

(7) Where a question or issue of fact is so referred, the arbitrator or arbiter shall report his findings to the comptroller.”.

Commencement Information

I16 Sch. para. 16 in force at 11.11.2013, see art. 1

17.  In section 54(2) (where patented invention is being worked abroad), after “means a country other than a member State” insert “or a member of the World Trade Organisation”. U.K.

Commencement Information

I17 Sch. para. 17 in force at 11.11.2013, see art. 1

[F1 18.— (1) In section 58(6)(a) (references of disputes as to Crown use), after “Act,” insert “or, in the case of a European patent (UK), has been allowed under any of the provisions in the Agreement on a Unified Patent Court,”. U.K.

(2) In section 58(12), after “Wales” insert “, the Isle of Man”.]

Textual Amendments

F1 Sch. para. 18 substituted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 1 (with art. 3)

19.—(1) In section 60(5) (meaning of infringement), after paragraph (f) insert— U.K.

“(g) it consists of the use by a farmer of the product of his harvest for propagation or multiplication by him on his own holding, where there has been a sale of plant propagating material to the farmer by the proprietor of the patent or with his consent for agricultural use;

(h) it consists of the use of an animal or animal reproductive material by a farmer for an agricultural purpose following a sale to the farmer, by the proprietor of the patent or with his consent, of breeding stock or other animal reproductive material which constitutes or contains the patented invention;

(i) it consists of—

(i) an act done in conducting a study, test or trial which is necessary for and is conducted with a view to the application of paragraphs 1 to 5 of article 13 of Directive 2001/82/EC or paragraphs 1 to 4 of article 10 of Directive 2001/83/EC, or

(ii) any other act which is required for the purpose of the application of those paragraphs.

[F2 (j) it consists of a use referred to in Article 27(c) of the Agreement on a Unified Patent Court;

(k) subject to subsection (6H), it consists of an act or use referred to in Article 27(k) of the Agreement on a Unified Patent Court.”].

(2) After section 60(6) insert—

“(6A) Schedule A1 contains—

(a) provisions restricting the circumstances in which subsection (5)(g) applies; and

(b) provisions which apply where an act would constitute an infringement of a patent but for subsection (5)(g).

(6B) For the purposes of subsection (5)(h), use for an agricultural purpose—

(a) includes making an animal or animal reproductive material available for the purposes of pursuing the farmer’s agricultural activity; but

(b) does not include sale within the framework, or for the purposes, of a commercial reproduction activity.

(6C) In paragraphs (g) and (h) of subsection (5) “sale” includes any other form of commercialisation.”.

[F3 (2A) After section 60(6G) insert—

“(6H) Subsection 5(k) applies to an act or use in relation to a European patent (UK) or a European patent with unitary effect, but does not apply to an act or use in relation to a patent granted by the comptroller.”.]

(3) In section 60(7)—

(a) in the definitions of “relevant ship” and “relevant aircraft, hovercraft or vehicle”, after “1983” insert “or which is a member of the World Trade Organisation”;

(b) in the definition of “exempted aircraft”, for “section 53 of the Civil Aviation Act 1949” substitute “section 89 of the Civil Aviation Act 1982(3)”;

(c) at the end insert―

““Directive 2001/82/EC” means Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products as amended by Directive 2004/28 of the European Parliament and of the Council(4);

“Directive 2001/83/EC” means Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use, as amended by Directive 2002/98/EC of the European Parliament and of the Council, by Commission Directive 2003/63/EC and by Directives 2004/24/EC and 2004/27/EC of the European Parliament and of the Council(5).”.

Textual Amendments

F2 Words in Sch. para. 19 inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 2(a) (with art. 3)

F3 Sch. para. 19(2A) inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 2(b) (with art. 3)

Commencement Information

I18 Sch. para. 19 in force at 11.11.2013, see art. 1

20.  In section 61(7) (proceedings for infringement of patent)(6), at the end insert― U.K.

“(d) in the Isle of Man, payment of the sum may be enforced as if it were a judgment or order of the court for the payment of money.”.

Commencement Information

I19 Sch. para. 20 in force at 11.11.2013, see art. 1

21.—(1) In the side note to section 62 (damages for infringement), for “Restrictions on recovery of” substitute “Further provisions as to”. U.K.

(2) In section 62(3), for the words from “no damages” onwards substitute—

“the court or the comptroller shall, when awarding damages or making an order for an account of profits in proceedings for an infringement of the patent committed before the decision to allow the amendment, take into account the following—

(a) whether at the date of infringement the defendant or defender knew, or had reasonable grounds to know, that he was infringing the patent;

(b) whether the specification of the patent as published was framed in good faith and with reasonable skill and knowledge;

(c) whether the proceedings are brought in good faith.”.

(3) After section 62(3) insert—

“(3A) Where in an action for infringement of a patent it is shown that the defendant knew, or had reason to believe, that he was committing an infringement, the damages awarded to the claimant shall be appropriate to the actual prejudice he suffered as a result of the infringement.

(3B) The court—

(a) in awarding such damages shall take into account all appropriate aspects, including in particular—

(i) the negative economic consequences, including any lost profits, which the claimant has suffered;

(ii) any unfair profits made by the defendant; and

(iii) elements other than economic factors, including the moral prejudice caused to the claimant by the infringement; or

(b) may where appropriate award such damages on the basis of the royalties or fees which would have been due had the defendant obtained a licence.”.

Commencement Information

I20 Sch. para. 21 in force at 11.11.2013, see art. 1

22.  In section 63(2) (relief for infringement of partially valid patent), for the words from “not grant relief” onwards substitute— U.K.

“, when awarding damages, costs or expenses or making an order for an account of profits, take into account the following—

(a) whether at the date of the infringement the defendant or defender knew, or had reasonable grounds to know, that he was infringing the patent;

(b) whether the specification of the patent was framed in good faith and with reasonable skill and knowledge;

(c) whether the proceedings are brought in good faith;

and any relief granted shall be subject to the discretion of the court or the comptroller as to costs or expenses and as to the date from which damages or an account should be reckoned. ”.

Commencement Information

I21 Sch. para. 22 in force at 11.11.2013, see art. 1

23.  In section 68 (effect of non-registration on infringement proceedings)― U.K.

(a) omit the words from “, the court or comptroller shall” to “occurring”; and

(b) before “unless” insert “, in proceedings for such an infringement, the court or comptroller shall not award him costs or expenses”.

Commencement Information

I22 Sch. para. 23 in force at 11.11.2013, see art. 1

24.  After section 76 insert— U.K.

“Biotechnological inventions

76A.— (1) Any provision of, or made under, this Act is to have effect in relation to a patent or an application for a patent which concerns a biotechnological invention, subject to the provisions of Schedule A2.

(2) Nothing in this section or Schedule A2 is to be read as affecting the application of any provision in relation to any other kind of patent or application for a patent.”.

Commencement Information

I23 Sch. para. 24 in force at 11.11.2013, see art. 1

[F4 24ZA.   In section 77 (effect of European patent (UK))— U.K.

(a) in subsections (4), (4A) and (5A), after “European Patent Convention” insert “or the Agreement on a Unified Patent Court”;

(b) in subsection (5)(a)—

(i) after “European Patent Convention” insert “or the Agreement on a Unified Patent Court”; and

(ii) at the end after “Enlarged Board of Appeal” insert “or is revoked and subsequently restored by the Unified Patent Court”;

(c) after subsection (9), insert—

“(10) Subsection (1) does not apply and is to be treated as never having applied in respect of a European patent (UK) whose unitary effect is registered by the European Patent Office in the Register for unitary patent protection (see, in particular, the Unitary Patent Regulation).”.

Textual Amendments

F4 Sch. paras. 24ZA-24ZD inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 3 (with art. 3)

24ZB.   After section 83, insert— U.K.

83A.    “European patent with unitary effect and Unified Patent Court

(1) Schedule A3 contains provision about the application of this Act in relation to the European patent with unitary effect.

(2) Schedule A4 contains provision about the jurisdiction of the Unified Patent Court in relation to the European patent (UK) and the European patent with unitary effect.”.

Textual Amendments

F4 Sch. paras. 24ZA-24ZD inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 3 (with art. 3)

24ZC.   In section 91 (evidence of conventions and instruments under conventions)— U.K.

(a) in subsection (1)(a), after “the Community Patent Convention” insert “, the Agreement on a Unified Patent Court”;

(b) in subsection (6), in the definition of “relevant convention court”, after “party to the relevant convention”, insert “but does include the Unified Patent Court;”.

Textual Amendments

F4 Sch. paras. 24ZA-24ZD inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 3 (with art. 3)

24ZD.   In section 92 (obtaining evidence for proceedings under the European Patent Convention), in subsections (1) and (5), after “European Patent Convention” insert “or proceedings before the Unified Patent Court”.] U.K.

Textual Amendments

F4 Sch. paras. 24ZA-24ZD inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 3 (with art. 3)

[F5 24A.   In section 92(5) (obtaining evidence for proceedings under the European Patent Convention), for “Perjury Act 1911” substitute “Perjury Act 1952 (an Act of Tynwald)” and omit “and Article 3(4) of the Perjury (Northern Ireland) Order 1979”.]  U.K.

Textual Amendments

F5 Sch. para. 24A inserted (1.6.2016) by The Patents (Isle of Man) (Amendment) Order 2016 (S.I. 2016/559), art. 1, Sch. para. 1

25.  In section 93 (enforcement of orders for costs), at the end insert— U.K.

“(d) in the Isle of Man, the order may be enforced as if it were a judgment or order of the court for the payment of money.”.

Commencement Information

I24 Sch. para. 25 in force at 11.11.2013, see art. 1

26.  Omit section 96. U.K.

Commencement Information

I25 Sch. para. 26 in force at 11.11.2013, see art. 1

27.  In section 97(2) (appeals from the comptroller), omit the words from “and the Patents Court” onwards. U.K.

Commencement Information

I26 Sch. para. 27 in force at 11.11.2013, see art. 1

28.  In section 107 (costs and expenses in proceedings before the comptroller), at the end insert— U.K.

“(6) In the Isle of Man, any order under this section for the payments of costs may be enforced as if it were a judgment or order of the court for the payment of money.”.

Commencement Information

I27 Sch. para. 28 in force at 11.11.2013, see art. 1

29.  In section 109 (falsification of register), for “indictment, to imprisonment” substitute “information, to custody”. U.K.

Commencement Information

I28 Sch. para. 29 in force at 11.11.2013, see art. 1

F6 30.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U.K.

Textual Amendments

F6 Sch. para. 30 omitted (1.6.2016) by virtue of The Patents (Isle of Man) (Amendment) Order 2016 (S.I. 2016/559), art. 1, Sch. para. 2

[F7 30A.   In section 124, after subsection (3) insert— U.K.

“(4) Any amendments made by regulations under the European Union (Withdrawal) Act 2018(1) to rules, regulations or orders under this Act, whether made before or after this provision comes into force, extend to the Isle of Man, subject to any modifications contained in an Order made by Her Majesty in Council under section 132(2).”.]

Textual Amendments

F7 Sch. para. 30A inserted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(2); 2020 c. 1, Sch. 5 para. 1(1)

31.  After section 124 (rules, regulations and orders; supplementary) insert— U.K.

“Use of electronic communications

124A.— (1) The comptroller may give directions as to the form and manner in which documents to be delivered to the comptroller—

(a) in electronic form; or

(b) using electronic communications,

are to be delivered to him.

(2) A direction under subsection (1) may provide that in order for a document to be delivered in compliance with the direction it shall be accompanied by one or more additional documents specified in the direction.

(3) Subject to subsections (14) and (15), if a document to which a direction under subsection (1) or (2) applies is delivered to the comptroller in a form or manner which does not comply with the direction the comptroller may treat the document as not having been delivered.

(4) Subsection (5) applies in relation to a case where—

(a) a document is delivered using electronic communications, and

(b) there is a requirement for a fee to accompany the document.

(5) The comptroller may give directions specifying—

(a) how the fee shall be paid; and

(b) when the fee shall be deemed to have been paid.

(6) The comptroller may give directions specifying that a person who delivers a document to the comptroller in electronic form or using electronic communications cannot treat the document as having been delivered unless its delivery has been acknowledged.

(7) The comptroller may give directions specifying how a time of delivery is to be accorded to a document delivered to him in electronic form or using electronic communications.

(8) A direction under this section may be given—

(a) generally;

(b) in relation to a description of cases specified in the direction;

(c) in relation to a particular person or persons.

(11) A direction under this section may be varied or revoked by a subsequent direction under this section.

(13) The delivery using electronic communications to any person by the comptroller of any document is deemed to be effected, unless the comptroller has otherwise specified, by transmitting an electronic communication containing the document to an address provided or made available to the comptroller by that person as an address of his for the receipt of electronic communications; and unless the contrary is proved such delivery is deemed to be effected immediately upon the transmission of the communication.

(14) A requirement of this Act that something must be done in the prescribed manner is satisfied in the case of something that is done—

(a) using a document in electronic form, or

(b) using electronic communications,

only if the directions under this section that apply to the manner in which it is done are complied with.

(15) In the case of an application made as mentioned in subsection (14)(a) or (b) above, a reference in this Act to the application not having been made in compliance with rules or requirements of this Act includes a reference to its not having been made in compliance with any applicable directions under this section.

(16) This section applies—

(a) to delivery at, in, with or to the Patent Office as it applies to delivery to the comptroller; and

(b) to delivery by the Patent Office as it applies to delivery by the comptroller.”.

Commencement Information

I29 Sch. para. 31 in force at 11.11.2013, see art. 1

32.  In section 125A (disclosure of invention(7)— U.K.

(a) in the side note, for “micro-organisms” substitute “biological material”;

(b) in subsection (1), for “requires for its performance the use of a micro-organism” substitute “involves the use of or concerns biological material”;

(c) in subsection (2)(a), for “micro-organism” substitute “biological material”.

Commencement Information

I30 Sch. para. 32 in force at 11.11.2013, see art. 1

33.  Omit section 126. U.K.

Commencement Information

I31 Sch. para. 33 in force at 11.11.2013, see art. 1

34.  After section 128 insert― U.K.

[F8 “Compulsory pharmaceutical] licences

128A.— (1) In this Act [F9 a “compulsory pharmaceutical licence”] means a compulsory licence granted under Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems(8) (referred to in this Act as “the Compulsory Licensing Regulation”).

(2) In the application to [F10 compulsory pharmaceutical] licences of the provisions of this Act listed in subsection (3)—

(a) references to a licence under a patent,

(b) references to a right under a patent, and

(c) references to a proprietary interest under a patent,

include [F11 a compulsory pharmaceutical] licence.

(3) The provisions referred to in subsection (2) are—

• sections 32 and 33 (registration of patents etc);

• section 37 (determination of right to patent after grant);

• section 38 (effect of transfer etc of patent under section 37), apart from subsection (2) and subsections (3) to (5) so far as relating to subsection (2);

• section 41 (amount of compensation);

• section 46(2) (notice of application for entry that licences are available as of right);

• section 57(1) and (2) (rights of third parties in respect of Crown use).

(4) In the following provisions references to this Act include the Compulsory Licensing Regulation—

• sections 97 to 99B, 101 to 103, 105 and 107 (legal proceedings);

• section 119 (service by post);

• section 120 (hours of business and excluded days);

• section 121 (comptroller’s annual report);

• section 123 (rules);

• section 124A (use of electronic communications);

• section 130(8) (disapplication of Part 1 of Arbitration Act 1996(9)).

(5) In section 108 (licences granted by order of comptroller) the reference to a licence under section 11, 38, 48 or 49 includes [F12 a compulsory pharmaceutical] licence.

(6) References in this Act to the Compulsory Licensing Regulation are to that Regulation as amended from time to time.

Supplementary protection certificates

128B.— (1) Schedule 4A contains provision about the application of this Act in relation to supplementary protection certificates and other provision about such certificates.

(2) In this Act a “supplementary protection certificate” means a certificate issued under—

(a) [F13 “Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6th May 2009 concerning the supplementary protection certificate for medicinal products], or

(b) Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products(10).”.

Textual Amendments

F8 Words in Sch. para. 34 substituted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(3)(a); 2020 c. 1, Sch. 5 para. 1(1)

F9 Words in Sch. para. 34 substituted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(3)(b); 2020 c. 1, Sch. 5 para. 1(1)

F10 Words in Sch. para. 34 substituted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(3)(c)(i); 2020 c. 1, Sch. 5 para. 1(1)

F11 Words in Sch. para. 34 substituted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(3)(c)(ii); 2020 c. 1, Sch. 5 para. 1(1)

F12 Words in Sch. para. 34 substituted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(3)(d); 2020 c. 1, Sch. 5 para. 1(1)

F13 Words in Sch. para. 34 substituted (1.6.2016) by The Patents (Isle of Man) (Amendment) Order 2016 (S.I. 2016/559), art. 1, Sch. para. 3

Commencement Information

I32 Sch. para. 34 in force at 11.11.2013, see art. 1

35.— [F14 (1)] In section 130(1) (interpretation)— U.K.

[F15 (a) at the end of the definition of “court” insert—

“(d) as respects the Isle of Man, the High Court of Justice of the Isle of Man;

or the Unified Patent Court, as respects the jurisdiction which it has by virtue of Schedule A4;”;]

(b) at the appropriate places insert—

[F16 ““Agreement on a Unified Patent Court” means the Agreement on a Unified Patent Court signed at Brussels on 19th February 2013;]

“biological material” means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;

“biotechnological invention” means an invention which concerns a product consisting of or containing biological material or a process by means of which biological material is produced, processed or used;

“electronic communication” has the same meaning as in the Electronic Communications Act 2000(11);

“enactment” includes an Act of Tynwald;

[F16 “European patent with unitary effect” has the same meaning as in Article 2 of the Unitary Patent Regulation;]

[F16 “Unified Patent Court” means the court established under the Agreement on a Unified Patent Court;]

[F16 “Unitary Patent Regulation” means Regulation (EU) No 1257/2012 of the European Parliament and of the Council of 17 December 2012 implementing enhanced cooperation in the area of the creation of unitary patent protection.”]

(c) in the definition of “formal requirements” for “section 17” substitute “section 15A”.

[F17 (2) In section 130(6), after paragraph (c), insert—

“(d) The Agreement on a Unified Patent Court;”.]

Textual Amendments

F14 Sch. para. 35 renumbered as Sch. para. 35(1) (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 4 (with art. 3)

F15 Sch. para. 35(1)(a) substituted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 4(a) (with art. 3)

F16 Words in Sch. para. 35(1)(b) inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 4(b) (with art. 3)

F17 Sch. para. 35(2) inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 4(c) (with art. 3)

Commencement Information

I33 Sch. para. 35 in force at 11.11.2013, see art. 1

36.  Before Schedule 1 insert— U.K.

Section 60(5)(g)

“SCHEDULE A1 U.K. Derogation from patent protection in respect of biotechnological inventions

Interpretation U.K.

1.   In this Schedule—

“the Council Regulation” means Council Regulation (EC) No. 2100/94 of 27th July 1994 on Community plant variety rights(12) [F18 as it had effect immediately before exit day];

“farmer’s own holding” means any land which a farmer actually exploits for plant growing, whether as his property or otherwise managed under his own responsibility and on his own account;

“the gazette” means the gazette published under section 34 of the Plant Varieties and Seeds Act 1964(13);

“protected material” means plant propagating material which incorporates material subject to a patent;

“relevant activity” means the use by a farmer of the product of his harvest for propagation or multiplication by him on his own holding, where the product of the harvest constitutes or contains protected material;

“relevant rights holder” means the proprietor of a patent to which protected material is subject;

“seed” includes seed potatoes;

“seed year” means the period from 1st July in one year to 30th June in the following year, both dates inclusive.

Specified species U.K.

2.   Section 60(5)(g) applies only to varieties of the following plant species and groups:

Name	Common Name
Fodder plants
Cicer arietinum L.	Chickpea milkvetch
Lupinus luteus L.	Yellow lupin
Medicago sativa L.	Lucerne
Pisum sativum L. (partim)	Field pea
Trifolium alexandrinum L.	Berseem/Egyptian clover
Trifolium resupinatum L.	Persian clover
Vicia faba	Field bean
Vicia sativa L	Common vetch
Cereals
Avena sativa	Oats
Hordeum vulgare L.	Barley
Oryza sativa L.	Rice
Phalaris canariensis L.	Canary grass
Secale cereale L.	Rye
X Triticosecale Wittm.	Triticale
Triticum aestivum L. emend. Fiori et Paol.	Wheat
Triticum durum Desf.	Durum wheat
Triticum spelta L.	Spelt wheat
Potatoes
Solanum tuberosum	Potatoes
Oil and fibre plants
Brassica napus L. (partim)	Swede rape
Brassica rapa L. (partim)	Turnip rape
Linum usitatissimum	Linseed with the exclusion of flax

Liability to pay equitable remuneration U.K.

3.— (1) If a farmer’s use of protected material is authorised by section 60(5)(g), he shall, at the time of the use, become liable to pay the relevant rights holder equitable remuneration.

(2) That remuneration must be sensibly lower than the amount charged for the production of protected material of the same variety in the same area with the holder’s authority.

(3) Remuneration is to be taken to be sensibly lower if it would be taken to be sensibly lower within the meaning of Article 14(3) fourth indent of the Council Regulation.

Exemption for small farmers U.K.

4.— (1) Paragraph 3 does not apply to a farmer who is considered to be a small farmer for the purposes of Article 14(3) third indent of the Council Regulation.

(2) It is for a farmer who claims to be a small farmer to prove that he is such a farmer.

Information to be supplied by farmer U.K.

5.— (1) At the request of a relevant rights holder (“H”), a farmer must tell H—

(a) his name and address;

(b) whether he has performed a relevant activity; and

(c) if he has performed such an activity, the address of the holding on which he performed it.

(2) If the farmer has performed such an activity, he must tell H whether he is—

(a) liable to pay remuneration as a result of paragraph 3; or

(b) not liable because he is a small farmer.

(3) If the farmer has told H that he is liable to pay remuneration as a result of paragraph 3, he must tell H—

(a) the amount of the protected material used;

(b) whether the protected material has been processed for planting; and

(c) if it has, the name and address of the person who processed it.

(4) The farmer must comply with sub-paragraphs (2) and (3) when complying with sub-paragraph (1).

(5) If the farmer has told H that he is liable to pay remuneration as a result of paragraph 3, he must (if H asks him to do so) tell H—

(a) whether he used any protected material with the authority of H within the same seed year; and

(b) if he did, the amount used and the name and address of the person who supplied it.

Information to be supplied by seed processor U.K.

6.— (1) On the request of a relevant rights holder, a seed processor shall supply the following information—

(a) the name and address of the seed processor;

(b) the address of the seed processor’s principal place of business; and

(c) whether the seed processor has processed seed of a species specified in paragraph 2 above.

(2) If the seed processor has processed seed of a species specified in paragraph 2 above he shall also supply the following information with the information referred to in sub-paragraph (1)—

(a) the name and address of the person for whom the processing was carried out;

(b) the amount of seed resulting from the processing;

(c) the date processing commenced;

(d) the date processing was completed;

(e) the place where processing was carried out.

Information to be supplied by relevant rights holder U.K.

7.   On the request of a farmer or a seed processor a relevant rights holder shall supply the following information—

(a) his name and address; and

(b) the amount of royalty charged for certified seed of the lowest certification category for seed containing that protected material.

Period in respect of which inquiry may be made U.K.

8.   A request may be made under paragraph 5, 6, and 7 in respect of the current seed year and the three preceding seed years.

Restriction on movement for processing from the holding U.K.

9.   No person shall remove or cause to be removed from a holding protected material in order to process it unless—

(a) he has the permission of the relevant rights holder in respect of that protected material;

(b) he has taken measures to ensure that the same protected material is returned from processing as is sent for processing and the processor has undertaken to him that the processor has taken measures to ensure that the same protected material is returned from processing as is sent for processing; or

(c) he has the protected material processed by a seed processor on the list of processors referred to in the gazette as being permitted to process seed away from a holding.

Confidentiality U.K.

10.— (1) A person who obtains information pursuant to this Schedule shall owe an obligation of confidence in respect of the information to the person who supplied it.

(2) Sub-paragraph (1) shall not have effect to restrict disclosure of information—

(a) for the purposes of, or in connection with, establishing the amount to be paid to the holder of rights pursuant to paragraph 3 and obtaining payment of that amount,

(b) for the purposes of, or in connection with, establishing whether a patent has been infringed, or

(c) for the purposes of, or in connection with, any proceedings for the infringement of a patent.

Formalities U.K.

11.— (1) A request for information under this Schedule, and any information given in response to such a request, must be in writing.

(2) Information requested under this Schedule must be given—

(a) within 28 days; or

(b) if the request specifies a longer period, within the specified period.

Remedies U.K.

12.— (1) If, in response to a request under this Schedule, a person—

(a) knowingly fails to provide information which he is required by this Schedule to give, or

(b) refuses to provide any such information,

the court may order him to provide it.

(2) Sub-paragraph (1) does not affect any of the court’s other powers to make orders.

(3) A person who knowingly provides false information in response to a request under this Schedule is liable in damages to the person who made the request.

(4) In any action for damages under sub-paragraph (3) the court must have regard, in particular to—

(a) how flagrant the defendant was in providing the false information, and

(b) any benefit which accrued to him as a result of his providing false information,

and shall award such additional damages as the justice of the case may require.

Section 76A

SCHEDULE A2 U.K. Biotechnological Inventions

1.   An invention shall not be considered unpatentable solely on the ground that it concerns—

(a) a product consisting of or containing biological material; or

(b) a process by which biological material is produced, processed or used.

2.   Biological material which is isolated from its natural environment or produced by means of a technical process may be the subject of an invention even if it previously occurred in nature.

3.   The following are not patentable inventions—

(a) the human body, at the various stages of its formation and development, and the simple discovery of one of its elements, including the sequence or partial sequence of a gene;

(b) processes for cloning human beings;

(c) processes for modifying the germ line genetic identity of human beings;

(d) uses of human embryos for industrial or commercial purposes;

(e) processes for modifying the genetic identity of animals which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes;

(f) any variety of animal or plant or any essentially biological process for the production of animals or plants, not being a microbiological or other technical process or the product of such a process.

4.   Inventions which concern plants or animals may be patentable if the technical feasibility of the invention is not confined to a particular plant or animal variety.

5.   An element isolated from the human body or otherwise produced by means of a technical process, including the sequence or partial sequence of a gene, may constitute a patentable invention, even if the structure of that element is identical to that of a natural element.

6.   The industrial application of a sequence or partial sequence of a gene must be disclosed in the patent application as filed.

7.   The protection conferred by a patent on a biological material possessing specific characteristics as a result of the invention shall extend to any biological material derived from that biological material through propagation or multiplication in an identical or divergent form and possessing those same characteristics.

8.   The protection conferred by a patent on a process that enables a biological material to be produced possessing specific characteristics as a result of the invention shall extend to biological material directly obtained through that process and to any other biological material derived from the directly obtained biological material through propagation or multiplication in an identical or divergent form and possessing those same characteristics.

9.   The protection conferred by a patent on a product containing or consisting of genetic information shall extend to all material, save as provided for in paragraph 3(a) above, in which the product is incorporated and in which the genetic information is contained and performs its function.

10.   The protection referred to in paragraphs 7, 8 and 9 above shall not extend to biological material obtained from the propagation or multiplication of biological material placed on the market by the proprietor of the patent or with his consent, where the multiplication or propagation necessarily results from the application for which the biological material was marketed, provided that the material obtained is not subsequently used for other propagation or multiplication.

11.   In this Schedule—

“essentially biological process” means a process for the production of animals and plants which consists entirely of natural phenomena such as crossing and selection;

“microbiological process” means any process involving or performed upon or resulting in microbiological material;

“plant variety” means a plant grouping within a single botanical taxon of the lowest known rank, which grouping can be—

(a)

defined by the expression of the characteristics that results from a given genotype or combination of genotypes; and

(b)

distinguished from any other plant grouping by the expression of at least one of the said characteristics; and

(c)

considered as a unit with regard to its suitability for being propagated unchanged.

[F19 SCHEDULE A3 U.K. EUROPEAN PATENT WITH UNITARY EFFECT

Meaning of “relevant statutory provisions” U.K.

1.   In this Schedule “relevant statutory provisions” means—

(a) the provisions of this Act which, by virtue of paragraph 2, apply in relation to the European patent with unitary effect, and

(b) the other provisions of this Act which, by virtue of the Unitary Patent Regulation, are to be treated as applying in relation to the European patent with unitary effect (see, in particular, Article 7 of that Regulation).

Provisions applied by this Schedule to the European patent with unitary effect U.K.

2.   The following provisions of this Act apply in relation to a European patent with unitary effect, subject to paragraphs 3 and 4—

• section 48 (compulsory licences: general);

• section 48A (compulsory licences: WTO proprietors);

• section 48B (compulsory licences: other cases);

• section 49 (provisions about licences under section 48);

• section 50 (exercise of powers on applications under section 48);

• section 50A (powers exercisable following merger and market investigations);

• section 51 (powers exercisable in consequence of report of Competition and Markets Authority);

• section 52 (opposition, appeal and arbitration);

• section 53 (compulsory licences; supplementary provisions);

• section 54 (special provisions where patented invention is being worked abroad);

• section 55 (use of patented inventions for services of the Crown);

• section 56 (interpretation, etc., of provisions about Crown use);

• section 57 (rights of third parties in respect of Crown use);

• section 57A (compensation for loss of profit);

• section 58(1) to (6) and (9A) to (13) (references of disputes as to Crown use);

• section 59 (special provisions as to Crown use during emergency);

• section 60 (meaning of infringement);

• section 64 (right to continue use begun before priority date);

• section 73(2) to (4) (Comptroller’s power to revoke patents on his own initiative);

• section 74A (opinions on matters prescribed in the rules);

• section 74B (reviews of opinions under section 74A);

• section 76A (biotechnological inventions);

• section 77(4) to (5A) (effect of European patent (UK));

• section 80(1) (authentic text of European patents and patent applications);

• sections 97 to 100 (legal proceedings) so far as they relate to proceedings which do not fall within the exclusive jurisdiction of the Unified Patent Court as set out in paragraph 1 of Schedule A4;

• section 101 (exercise of comptroller’s discretionary powers);

• section 102 (right of audience, &c in proceedings before comptroller);

• sections 103 (extension of privilege for communications with solicitors relating to patent proceedings) and 105 (extension of privilege in Scotland for communications relating to patent proceedings) so far as they relate to proceedings before the comptroller;

• section 107 (costs and expenses in proceedings before the comptroller);

• section 108 (licences granted by order of comptroller);

• section 110 (unauthorised claim of patent rights);

• section 116 (immunity of department as regards official acts);

• section 118 (information about patent applications and patents, and inspection of documents);

• section 123 (rules);

• section 124 (rules, regulations and orders; supplementary);

• section 125 (extent of invention);

• section 128A (EU compulsory licences);

• section 128B (supplementary protection certificates).

Manner of application of relevant statutory provisions U.K.

3.   The relevant statutory provisions apply in relation to a European patent with unitary effect in the same way as they apply in relation to a European patent (UK).

Modifications of relevant statutory provisions U.K.

4.— (1) In their application in relation to the European patent with unitary effect, the relevant statutory provisions which are referred to in this paragraph have effect subject to the modifications set out in this paragraph.

(2) In section 7(2)(b), the reference to the United Kingdom is a reference to any of the Participating Member States.

(3) In sections 30(7) and 31(7), references to proceedings by virtue of section 61 or 69 are references to equivalent proceedings in the Unified Patent Court.

(4) In sections 33(1)(a), 33(4), 37(2), 37(7), 38(2) and 38(3), the reference to registration is a reference to registration in the Register for unitary patent protection.

(5) In sections 48(1)(b), 48B(4), 50A(4), 51(3), 53(3), and 53(4), the reference to the register is a reference to the Register for unitary patent protection.

(6) In sections 48(2)(b), 50A(4), 51(3), 53(3), 53(4) and 53(5), the reference to making an entry is a reference to directing the making of an entry.

(7) In sections 48B(2)(b) and 50(2)(a), the reference to the journal is a reference to the European Patent Bulletin.

(8) In section 55(5)(b), the reference to the Patent Office is a reference to the European Patent Office.

(9) In section 59(2), the reference to section 69 includes a reference to Article 67 of the European Patent Convention.

(10) In section 60—

(a) in subsections (1), (2), and (5)(d), (e) and (f), the references to the United Kingdom are references to the territory of a Contracting Member State in which the European patent with unitary effect has effect;

(b) in subsection (7)—

(i) in the definition of “relevant ship” and “relevant aircraft, hovercraft or vehicle”, the reference to the United Kingdom is a reference to a Contracting Member State in which the European patent with unitary effect has effect; and

(ii) in the definition of “exempted aircraft”, the reference to an aircraft to which section 89 of the Civil Aviation Act 1982 applies is a reference to an aircraft other than an aircraft of a Contracting Member State in which the European patent with unitary effect has effect.

Interpretation U.K.

5.   In this Schedule—

(a) “Contracting Member State” has the same meaning as in Article 2(c) of the Agreement on a Unified Patent Court;

(b) the following expressions have the same meanings as in Article 2 of the Unitary Patent Regulation—

• Participating Member State;

• Register for unitary patent protection; and

(c) in relation to the United Kingdom, references to a Contracting Member State or a Participating Member State are to be construed in accordance with section 132(2).”].

Textual Amendments

F18 Words in Sch. para. 36 inserted (31.12.2020) by The Patents (Isle of Man) (Amendment) (EU Exit) Order 2019 (S.I. 2019/1327), arts. 1, 2(4); 2020 c. 1, Sch. 5 para. 1(1)

F19 Words in Sch. para. 36 inserted (coming into force in accordance with art. 1(2) of the amending S.I.) by The Patents (Isle of Man) (Amendment) Order 2017 (S.I. 2017/162), Sch. para. 5 (with art. 3)

Commencement Information

I34 Sch. para. 36 in force at 11.11.2013, see art. 1

37.  After Schedule 4 insert― U.K.

Section 128B(1)

“SCHEDULE 4A U.K. SUPPLEMENTARY PROTECTION CERTIFICATES

References to patents etc U.K.

1.— (1) In the application to supplementary protection certificates of the provisions of this Act listed in sub-paragraph (2)—

(a) references to a patent are to a supplementary protection certificate;

(b) references to an application or the applicant for a patent are to an application or the applicant—

(i) for a supplementary protection certificate, or

(ii) for an extension of the duration of a supplementary protection certificate;

(c) references to the proprietor of a patent are to the holder of a supplementary protection certificate;

(d) references to the specification of a patent are to the text of a supplementary protection certificate;

(e) references to a patented product or an invention (including a patented invention) are to a product for which a supplementary protection certificate has effect;

(f) references to a patent having expired or having been revoked are to a supplementary protection certificate having lapsed or having been declared invalid;

(g) references to proceedings for the revocation of a patent are to proceedings—

(i) for a decision that a supplementary protection certificate has lapsed, or

(ii) for a declaration that a supplementary protection certificate is invalid;

(h) references to the issue of the validity of a patent include the issue of whether a supplementary protection certificate has lapsed or is invalid.

(2) The provisions referred to in sub-paragraph (1) are—

• section 14(1), (9) and (10) (making of application);

• section 19(1) (general power to amend application before grant);

• sections 20A and 20B (reinstatement of applications);

• section 21 (observations by third party on patentability);

• section 27 (general power to amend specification after grant);

• section 29 (surrender of patents);

• sections 30 to 36, 37(1) to (3) and (5) to (9) and 38 (property in patents and applications, and registration);

• sections 39 to 59 (employees’ inventions, licences of right and compulsory licences and use of patented inventions for services of the Crown);

• sections 60 to 71 (infringement);

• section 74(1) and (7) (proceedings in which validity of patent may be put in issue);

• section 75 (amendment of patent in infringement or revocation proceedings);

• sections 103 and 105 (privilege for communications relating to patent proceedings);

• section 108 (licences granted by order of comptroller);

• sections 110 and 111 (unauthorised claim of patent rights or that patent has been applied for);

• section 116 (immunity of department as regards official acts);

• sections 117 to 118 (administrative provisions);

• section 123 (rules);

• section 130 (interpretation).

2.— (1) In the case of the provisions of this Act listed in sub-paragraph (2), paragraph 1 applies in relation to an application for a supplementary protection certificate only if the basic patent expires before the certificate is granted.

(2) The provisions referred to in sub-paragraph (1) are—

• section 20B(3) to (6A) (effect of reinstatement under section 20A);

• section 55(5) and (7) (use of patented inventions for services of the Crown);

• section 58(10) (disputes as to Crown use);

• section 69 (infringement of rights conferred by publication of application);

• section 117A(3) to (7) (effect of resuscitating a withdrawn application under section 117).

References to this Act etc U.K.

3.— (1) In the provisions of this Act listed in sub-paragraph (2)—

(a) references to this Act include the Medicinal Products Regulation and the Plant Protection Products Regulation, and

(b) references to a provision of this Act include any equivalent provision of the Medicinal Products Regulation and the Plant Protection Products Regulation.

(2) The provisions referred to in sub-paragraph (1) are—

• sections 20A and 20B (reinstatement of applications);

• section 21 (observations by third party on patentability);

• section 69 (infringement of rights conferred by publication of application);

• section 74(1) and (7) (proceedings in which validity of patent may be put in issue);

• sections 97 to 99B, 101 to 103, 105 and 107 (legal proceedings);

• section 116 (immunity of department as regards official acts);

• sections 117 and 118 to 121 (administrative provisions);

• section 122 (Crown’s right to sell forfeited articles);

• section 123 (rules);

• section 124A (use of electronic communications);

• section 130 (interpretation).

Other references U.K.

4.— (1) In the application of section 21(1) (observations by third party on patentability) to supplementary protection certificates, the reference to the question whether the invention is a patentable invention is to the question whether the product is one for which a supplementary protection certificate may have effect.

(2) In the application of section 69(2) (conditions for infringement of rights conferred by publication of application) to supplementary protection certificates, the condition in paragraph (b) is that the act would, if the certificate had been granted on the date of the publication of the application, have infringed not only the certificate as granted but also the certificate for which the application was made.

Fees U.K.

5.— (1) A supplementary protection certificate does not take effect unless—

(a) the prescribed fee is paid before the end of the prescribed period, or

(b) the prescribed fee and any prescribed additional fee are paid before the end of the period of six months beginning immediately after the prescribed period.

Interpretation U.K.

6.— (1) Expressions used in this Act that are defined in the Medicinal Products Regulation or the Plant Protection Products Regulation have the same meaning as in that Regulation.

(2) References in this Act to, or to a provision of, the Medicinal Products Regulation or the Plant Protection Products Regulation are to that Regulation or that provision as amended from time to time.

7.   In this Act—

(a) “the Medicinal Products Regulation” means [F20 Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6th May 2009 concerning the supplementary protection certificate for medicinal products], and

(b) “the Plant Protection Products Regulation” means Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products(14). 

[F21 Transitional provision U.K.

8.— (1) A reference (express or implied) in this Act to the Medicinal Products Regulation, or a provision of it, is to be read as being or (subject to context) including a reference to the old Regulation, or the corresponding provision of the old Regulation, in relation to times, circumstances or purposes in relation to which the old Regulation, or that provision, had effect.

(2) Other than in relation to times, circumstances or purposes referred to in sub-paragraph (1), anything done, or having effect as if done, under (or for the purposes of or in reliance on) the old Regulation or a provision of the old Regulation and in force or effective immediately before 1st June 2016 (the day on which the Patents (Isle of Man) (Amendment) Order 2016 came into force) has effect on or after that date for the purposes of this Act as if done under (or for the purpose of or in reliance on) the Medicinal Products Regulation or the corresponding provision of it.

(3) In this paragraph “the old Regulation” means Council Regulation (EEC) No 1768/92 of 18th June 1992 concerning the creation of a supplementary protection certificate for medicinal products.”].

Textual Amendments

F20 Words in Sch. para. 37 substituted (1.6.2016) by The Patents (Isle of Man) (Amendment) Order 2016 (S.I. 2016/559), art. 1, Sch. para. 4(a)

F21 Words in Sch. para. 37 inserted (1.6.2016) by The Patents (Isle of Man) (Amendment) Order 2016 (S.I. 2016/559), art. 1, Sch. para. 4(b)

Commencement Information

I35 Sch. para. 37 in force at 11.11.2013, see art. 1

(1)

1976 c.44 (Isle of Man).

(2)

1857 c.44.

(3)

1982 c.16.

(4)

OJ No. L311, 28.11.2001, p.1.

(5)

OJ No, L136, 30.4.2004, p.58.

(6)

Section 61(7) was inserted by section 11 of the Patents Act 2004 (c.16).

(7)

Section 125A was inserted by paragraph 30 of Schedule 5 to the Copyright, Designs and Patents Act 1988 (c.48).

(8)

OJ No. L 157, 9.6.2006, p.1.

(9)

1996 c.23.

(10)

OJ No. L 198, 8.8.1996, p.30.

(11)

2000 c.7.

(12)

OJ No. L 227, 1.9.1994, p.1.

(13)

1964 c.14.

(14)

OJ No. L 198, 8.8.1996, p.30.